8CAE
 
 | Crystal structure of SARS-CoV-2 Mpro-H172Y mutant in complex with nirmatrelvir | Descriptor: | (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, Non-structural protein 11 | Authors: | El Kilani, H, Hilgenfeld, R. | Deposit date: | 2023-01-24 | Release date: | 2025-08-06 | Last modified: | 2025-09-03 | Method: | X-RAY DIFFRACTION (2.65 Å) | Cite: | 13b-K and Nirmatrelvir Resistance Mutations of SARS-CoV-2 Main Protease: Structural, Biochemical, and Biophysical Characterization of Free Enzymes and Inhibitor Complexes Crystals, 15, 2025
|
|
9F13
 
 | Crystal structure of HLA-C*12:02 in complex with KAYNVTQAF (KF9), a 9-mer epitope from SARS-CoV-2 Nucleocapsid (N266-274) | Descriptor: | Beta-2-microglobulin, HLA class I histocompatibility antigen C alpha chain, Nucleoprotein | Authors: | Ahn, Y.M, Maddumage, J.C, Chatzileontiadou, D.S.M, Gras, S. | Deposit date: | 2024-04-18 | Release date: | 2025-08-06 | Last modified: | 2025-09-10 | Method: | X-RAY DIFFRACTION (1.61 Å) | Cite: | Molecular basis of potent antiviral HLA-C-restricted CD8 + T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope. Nat Commun, 16, 2025
|
|
9HLJ
 
 | Crystal structure of GV37-TCR in complex with HLA-C*12:02 with KAYNVTQAF (KF9), a 9-mer epitope from SARS-CoV-2 Nucleocapsid (N266-274) | Descriptor: | 1,2-ETHANEDIOL, Beta-2-microglobulin, GV37-TCR alpha chain, ... | Authors: | Ahn, Y.M, Maddumage, J.C, Chatzileontiadou, D.S.M, Gras, S. | Deposit date: | 2024-12-05 | Release date: | 2025-08-06 | Last modified: | 2025-09-10 | Method: | X-RAY DIFFRACTION (2.54 Å) | Cite: | Molecular basis of potent antiviral HLA-C-restricted CD8 + T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope. Nat Commun, 16, 2025
|
|
9JRC
 
 | Crystal structure of SARS-CoV-2 receptor-binding domain complexed with squirrel ACE2 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme, ... | Authors: | Lan, J, Nan, X. | Deposit date: | 2024-09-29 | Release date: | 2025-08-06 | Last modified: | 2025-10-15 | Method: | X-RAY DIFFRACTION (3.16 Å) | Cite: | Cross-species recognition of squirrel ACE2 by the receptor binding domains of SARS-CoV-2, RaTG13, PCoV-GD and PCoV-GX. Structure, 33, 2025
|
|
9KUD
 
 | Crystal structure of SARS-CoV-2 JN.1 variant RBD complexed with squirrel ACE2 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme, Spike protein S1, ... | Authors: | Lan, J, Wang, C.H. | Deposit date: | 2024-12-03 | Release date: | 2025-08-06 | Last modified: | 2025-10-22 | Method: | X-RAY DIFFRACTION (3.14 Å) | Cite: | Cross-species recognition of squirrel ACE2 by the receptor binding domains of SARS-CoV-2, RaTG13, PCoV-GD and PCoV-GX. Structure, 33, 2025
|
|
9M2V
 
 | |
7IJN
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB175 (Mac1-x10181) | Descriptor: | (1R,2S)-2-(1H-indazol-4-yl)cyclopentane-1-carboxylic acid, DIMETHYL SULFOXIDE, Non-structural protein 3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Donald, J.R, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.22 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJO
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB177 (Mac1-x10183) | Descriptor: | (1R,2S)-2-(isoquinolin-6-yl)cyclopentane-1-carboxylic acid, Non-structural protein 3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Donald, J.R, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.181 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJP
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB179 (Mac1-x10184) | Descriptor: | (1R,2S)-2-(1-methyl-1H-1,3-benzimidazol-6-yl)cyclopentane-1-carboxylic acid, DIMETHYL SULFOXIDE, Non-structural protein 3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Donald, J.R, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.22 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJQ
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 macrodomain in complex with POB176 (Mac1-x10199) | Descriptor: | (1R,2S)-2-(1,3-benzoxazol-5-yl)cyclopentane-1-carboxylic acid, Non-structural protein 3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Donald, J.R, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.21 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJR
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0208 (Mac1-x10313) | Descriptor: | (1R,2R)-2-(isoquinolin-6-yl)cyclopentane-1-carboxylic acid, DIMETHYL SULFOXIDE, Non-structural protein 3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.206 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJS
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0209 (Mac1-x10314) | Descriptor: | (1R,2R)-2-(1,3-benzothiazol-6-yl)cyclopentane-1-carboxylic acid, DIMETHYL SULFOXIDE, Non-structural protein 3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.16 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJT
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0185 (Mac1-x10331) | Descriptor: | (2P)-2-(1,3-benzothiazol-6-yl)cyclopent-1-ene-1-carboxylic acid, DIMETHYL SULFOXIDE, Non-structural protein 3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Donald, J.R, Butler, W.T.W, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.145 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJU
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0206 (Mac1-x10390) | Descriptor: | (2P)-2-(isoquinolin-6-yl)cyclopent-1-ene-1-carboxylic acid, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.295 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJV
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0207 (Mac1-x10395) | Descriptor: | (2M)-2-(quinoxalin-6-yl)cyclopent-1-ene-1-carboxylic acid, DIMETHYL SULFOXIDE, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.27 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJW
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0208 (Mac1-x10399) | Descriptor: | (1R,2R)-2-(isoquinolin-6-yl)cyclopentane-1-carboxylic acid, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.607 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJX
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0209 (Mac1-x10400) | Descriptor: | (1R,2R)-2-(1,3-benzothiazol-6-yl)cyclopentane-1-carboxylic acid, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.381 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJY
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0185 (Mac1-x10407) | Descriptor: | (2P)-2-(1,3-benzothiazol-6-yl)cyclopent-1-ene-1-carboxylic acid, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Donald, J.R, Butler, W.T.W, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.481 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IJZ
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0221 (Mac1-x10516) | Descriptor: | (2P)-2-(quinolin-6-yl)cyclopent-1-ene-1-carboxylic acid, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Shaw, A, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.32 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IK0
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0211 (Mac1-x10525) | Descriptor: | (1R,2R)-2-(quinoxalin-6-yl)cyclopentane-1-carboxylic acid, GLYCEROL, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.369 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IK1
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0215 (Mac1-x10529) | Descriptor: | (1R,2R)-2-(2-amino-1,3-benzothiazol-6-yl)cyclopentane-1-carboxylic acid, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.34 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IK2
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0228 (Mac1-x10558) | Descriptor: | (2P)-2-(2-carbamamido-1,3-benzothiazol-6-yl)cyclopent-1-ene-1-carboxylic acid, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.151 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IK3
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0212 (Mac1-x10580) | Descriptor: | (1R,2R)-2-(quinolin-6-yl)cyclopentane-1-carboxylic acid, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.298 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IK4
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0213 (Mac1-x10581) | Descriptor: | (1R,2R)-2-(quinolin-7-yl)cyclopentane-1-carboxylic acid, DIMETHYL SULFOXIDE, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.15 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|
7IK5
 
 | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group -- Crystal Structure of SARS-CoV-2 NSP3 Macrodomain in complex with POB0216 (Mac1-x10584) | Descriptor: | (2P)-2-(2-amino-1,3-benzothiazol-6-yl)cyclopent-1-ene-1-carboxylic acid, DIMETHYL SULFOXIDE, Papain-like protease nsp3 | Authors: | Aschenbrenner, J.C, Watt, G, Marples, P.G, Wang, X, Schuller, M, O'Brien, P, Fearon, D, von Delft, F. | Deposit date: | 2025-08-04 | Release date: | 2025-08-13 | Method: | X-RAY DIFFRACTION (1.199 Å) | Cite: | Group deposition of SARS-CoV-2 NSP3 Macrodomain in complex with inhibitors from the O'Brien group To Be Published
|
|